文献速递胰腺与胆道疾病消化道肿瘤与早癌

ENPP1调控细胞外嘌呤代谢驱动胰腺炎相关胰腺癌

ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer.
PubMed 文献 · Gastroenterology · 2026-01-19

该研究通过人类CP与CP-PDAC样本的多组学分析及小鼠模型,揭示ENPP1调控的细胞外嘌呤代谢在胰腺炎-癌转化中的关键作用:腺泡细胞损伤释放嘌呤核苷酸,经胰腺星状细胞表面ENPP1-CD73降解为腺苷,激活星状细胞并促进纤维化,进而通过CXCL17招募免疫抑制细胞,形成免疫抑制微环境。ENPP1被证实为PDAC免疫治疗及胰腺炎-癌转化早期干预的有效靶点。

要点

  • ENPP1-CD73轴将嘌呤核苷酸降解为腺苷,激活胰腺星状细胞并促进纤维化。
  • 活化的星状细胞释放CXCL17,招募MDSC和Treg,形成免疫抑制微环境。
  • ENPP1是PDAC免疫治疗及胰腺炎-癌转化早期干预的潜在靶点。

核心结论

  • ENPP1调控的细胞外嘌呤代谢促进胰腺炎介导的胰腺癌发生,并可作为胰腺癌发生的潜在治疗靶点。

研究设计与样本

  • 对CP和CP-PDAC患者胰腺样本进行转录组、蛋白质组和代谢组的多组学分析。
  • 在Ptf1aCre/+; LSL-KrasG12D/+小鼠和Ptf1aCre/+; LSL-KrasG12D/+; Enpp1小鼠中构建CP-PDAC模型。
  • 对上述小鼠胰腺组织进行单细胞测序分析,揭示免疫微环境在胰腺炎-癌进展中的作用。
  • 在原位移植模型和CP-PDAC模型小鼠中研究药物抑制ENPP1的效果。

主要发现

  • CP和CP-PDAC患者样本的多组学分析显示,ENPP1调控的细胞外嘌呤代谢在胰腺炎-癌转化中起重要作用。
  • 机制上,胰腺腺泡细胞的炎症损伤导致嘌呤核苷酸代谢物释放,经胰腺星状细胞表面的ENPP1-CD73降解为腺苷,激活星状细胞并促进纤维化。
  • 活化的胰腺星状细胞释放CXCL17,招募髓源性抑制细胞和调节性T细胞,导致免疫抑制效应。
  • ENPP1被证实为PDAC免疫治疗和胰腺炎-癌转化早期干预的有效靶点。

临床怎么用

  • ENPP1可作为胰腺炎-癌转化早期干预的潜在靶点。
  • ENPP1抑制可能成为PDAC免疫治疗的策略之一。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Patients with chronic pancreatitis (CP) have a higher risk of developing pancreatic ductal adenocarcinoma (PDAC). Although pancreatitis has been found to promote PDAC initiation and progression, its role in PDAC tumorigenesis remains poorly understood. METHODS: A multiomics analysis of the transcriptome, proteome, and metabolome was performed in human pancreatic samples from patients with CP and CP-related PDAC (CP-PDAC). The CP-PDAC model was constructed in Ptf1aCre/+; LSL-KrasG12D/+ mice and Ptf1aCre/+; LSL-KrasG12D/+; ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) mice. Single-cell sequencing analysis of pancreatic tissue samples from Ptf1aCre/+; LSL-KrasG12D/+ mice and Ptf1aCre/+; LSL-KrasG12D/+; Enpp1 mice revealed the role of the immune microenvironment in the progression from pancreatitis to cancer. Pharmacologic ENPP1 inhibition was studied in the orthotopic transplantation model and CP-PDAC model mice. RESULTS: Multiomics analysis of samples from patients with CP and CP-PDAC revealed that ENPP1-regulated extracellular purine metabolism plays an important role in pancreatitis-cancer transformation. Mechanistically, inflammatory damage to pancreatic acinar cells leads to the release of purine nucleotide metabolites, which are degraded by ENPP1-CD73 on the surface of pancreatic stellate cells into adenosine. This process activates pancreatic stellate cells and promotes fibrosis. Activated pancreatic stellate cells then release CXCL17, which recruits myeloid-derived suppressor cells and regulatory T cells in the microenvironment, resulting in immunosuppressive effects. Finally, ENPP1 was confirmed to be an effective target for immunotherapy in PDAC and early intervention in pancreatitis-cancer transformation. CONCLUSIONS: The study results identified ENPP1 as a contributor to pancreatitis-mediated pancreatic cancer and a potential therapeutic target for pancreatic carcinogenesis.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Ma Z, Dong M, Pan H, et al. ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer. Gastroenterology. 2026. PMID: 41553309. doi:10.1053/j.gastro.2025.09.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。